BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8071118)

  • 1. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
    Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
    Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.
    Abe S; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
    Anticancer Res; 1999; 19(5C):4581-6. PubMed ID: 10650814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.
    Kubota T; Egawa T; Otani Y; Furukawa T; Saikawa Y; Yoshida M; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2003; 23(1B):583-7. PubMed ID: 12680150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
    Nakamura R; Saikawa Y; Kubota T; Kumagai A; Kiyota T; Ohashi M; Yoshida M; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2006; 26(2B):1433-7. PubMed ID: 16619555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
    Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
    Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
    Yamaue H; Tanimura H; Noguchi K; Hotta T; Tani M; Tsunoda T; Iwahashi M; Tamai M; Iwakura S
    Br J Cancer; 1992 Nov; 66(5):794-9. PubMed ID: 1419622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
    Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
    Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer.
    Fujita K; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
    Anticancer Res; 1998; 18(3B):1973-8. PubMed ID: 9677452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of chemosensitivity test for advanced colorectal cancer.
    Kabeshima Y; Kubota T; Watanabe M; Hasegawa H; Furukawa T; Kitajima M
    Anticancer Res; 2002; 22(5):3033-7. PubMed ID: 12530038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience.
    Wu B; Zhu JS; Zhang Y; Shen WM; Zhang Q
    World J Gastroenterol; 2008 May; 14(19):3064-8. PubMed ID: 18494060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of chemosensitivity testing using the MTT assay.
    Furukawa T; Kubota T; Suto A; Takahara T; Yamaguchi H; Takeuchi T; Kase S; Kodaira S; Ishibiki K; Kitajima M
    J Surg Oncol; 1991 Nov; 48(3):188-93. PubMed ID: 1943116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.
    Suganuma K; Kubota T; Saikawa Y; Abe S; Otani Y; Furukawa T; Kumai K; Hasegawa H; Watanabe M; Kitajima M; Nakayama H; Okabe H
    Cancer Sci; 2003 Apr; 94(4):355-9. PubMed ID: 12824904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: a pilot study of MTT assay in vitro and outcome analysis of 10 patients.
    Xu JM; Song ST; Tang ZM; Jiang ZF; Liu XQ; Zhang J; Liu XW; Paradiso A
    Am J Clin Oncol; 2001 Jun; 24(3):259-63. PubMed ID: 11404497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay.
    Yamaue H; Tanimura H; Nakamori M; Noguchi K; Iwahashi M; Tani M; Hotta T; Murakami K; Ishimoto K
    Dis Colon Rectum; 1996 Apr; 39(4):416-22. PubMed ID: 8878502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers as detected by MTT assay.
    Abe S; Kubota T; Saikawa Y; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2002; 22(6B):3605-10. PubMed ID: 12552963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay.
    Maeda S; Saikawa Y; Kubota T; Aoki M; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2003; 23(4):3147-50. PubMed ID: 12926047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.